Evidence map›Paper›PMID 40158387›Full record

ArticleEBioMedicine2025

Foetal cortical expansion is associated with neurodevelopmental outcome at 2-years in congenital heart disease: a longitudinal follow-up study.

Siân Wilson, Hyuk Jin Yun, Anjali Sadhwani, Henry A Feldman, Seungyoon Jeong, Nicholas Hart, Kaysi Herrera Pujols, Jane W Newburger, P Ellen Grant, Caitlin K Rollins and 1 more

Abstract read
In one paragraph

Article in EBioMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Siân WilsonFetal-Neonatal Neuroimaging & Developmental Science Center, Boston Children's Hospital, Boston, MA, 02115, USA; Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, 02115, USA. Electronic address: sian.wilson@childrens.harvard.edu.
Hyuk Jin YunFetal-Neonatal Neuroimaging & Developmental Science Center, Boston Children's Hospital, Boston, MA, 02115, USA; Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, 02115, USA.
Anjali SadhwaniDepartment of Psychiatry and Behavioral Sciences, Boston Children's Hospital, Boston, MA, 02115, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, 02115, USA.
Henry A FeldmanDivision of Newborn Medicine, Boston Children's Hospital, Boston, MA, 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, 02115, USA; Biostatistics and Research Design Center, Boston Children's Hospital, Boston, MA, 02115, USA.
Seungyoon JeongFetal-Neonatal Neuroimaging & Developmental Science Center, Boston Children's Hospital, Boston, MA, 02115, USA; Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, 02115, USA.
Nicholas HartDepartment of Neurology, Boston Children's Hospital, Boston, MA, 02115, USA.
Kaysi Herrera PujolsDepartment of Neurology, Boston Children's Hospital, Boston, MA, 02115, USA.
Jane W NewburgerDepartment of Cardiology, Boston Children's Hospital, Boston, MA, 02115, USA.
P Ellen GrantFetal-Neonatal Neuroimaging & Developmental Science Center, Boston Children's Hospital, Boston, MA, 02115, USA; Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, 02115, USA; Department of Radiology, Boston Children's Hospital, Boston, MA, 02115, USA.
Caitlin K RollinsDepartment of Neurology, Boston Children's Hospital, Boston, MA, 02115, USA.
Kiho ImFetal-Neonatal Neuroimaging & Developmental Science Center, Boston Children's Hospital, Boston, MA, 02115, USA; Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, 02115, USA. Electronic address: Kiho.Im@childrens.harvard.edu.

Funding

Genetic and Hemodynamic Effects on Prenatal Cortical Development in Congenital Heart DiseaseR01NS114087 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI IM, KIHO · 2020 to 2024
$2.8M
Measuring cortical plate and subplate thickness in the human fetal brain from magnetic resonance imagesR01EB031170 · NIBIB · BOSTON CHILDREN'S HOSPITAL · PI IM, KIHO · 2021 to 2025
$2.5M
Fetal Brain MRI as a Predictor of Late Neurodevelopmental Outcome in Congenital Heart DiseaseR01NS121334 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI Caitlin Rollins · 2022 to 2026
$2.2M
NIBIB NIH HHS R01 EB031170NINDS NIH HHS R01 NS114087NINDS NIH HHS R01 NS121334
6 · The paper itself

Abstract

backgroundIn adolescents and adults with complex congenital heart disease (CHD), abnormal cortical folding is a putative predictor of poor neurodevelopmental outcome. However, it is unknown when this relationship first emerges. We test the hypothesis that it begins in utero, when the brain starts to gyrify and folding patterns first become established.

methodsWe carried out a prospective, longitudinal case-control study, acquiring foetal MRIs at two timepoints in utero, (Scan 1 = 20-30 Gestational Weeks (GW) and Scan 2 = 30-39 GW), then followed up participants at two years of age to assess neurodevelopmental outcomes. We used normative modelling to chart growth trajectories of surface features across 60 cortical regions in a control population (n = 157), then quantified the deviance of each foetus with CHD (n = 135) and explored the association with neurodevelopmental outcomes at two years of age.

findingsDifferences in cortical development between CHD and Control foetuses only emerged after 30 GW, and lower regional cortical surface area growth was correlated with poorer neurodevelopmental outcomes at two years of age in the CHD group.

interpretationThis work highlights the third trimester specifically as a critical period in brain development for foetuses with CHD, where the reduced surface area expansion in specific cortical regions becomes consequential in later life, and predictive of neurodevelopmental outcome in toddlerhood.

fundingThis research was supported by the NINDS (R01NS114087, K23NS101120) and NIBIB (R01EB031170) of the NIH, PHN Scholar Award, AAN Clinical Research Training Fellowship, BBRF Young Investigator Awards, and the Farb Family Fund.

Indexed as

Cerebral CortexHeart Defects, CongenitalNeurodevelopmental DisordersAdolescentAdultCase-Control StudiesChild, PreschoolFemaleFetusFollow-Up StudiesGestational AgeHumansLongitudinal StudiesMagnetic Resonance ImagingMalePregnancyCongenital heart diseaseCortexFoetalLongitudinalMRINeurodevelopment

Identifiers

PMID40158387
PMCPMC11994330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.